ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TACLONEX TOPICAL SUSPENSION
Psoriasis
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

TACLONEX TOPICAL SUSPENSION Rx

Generic Name and Formulations:
Calcipotriene (as hydrate) 0.005% + betamethasone dipropionate 0.064%.

Company:
LEO Pharma Inc.

Therapeutic Use:

Indications for TACLONEX TOPICAL SUSPENSION:

Plaque psoriasis of the scalp in patients 12–17yrs. Plaque psoriasis of the scalp and body in patients ≥18yrs.

Adult:

Apply to affected areas once daily for up to 8 weeks or until clear. 12–17yrs: max 60g/week. ≥18yrs: max 100g/week. Do not occlude.

Children:

<12yrs: not established.

See Also:

TACLONEX OINTMENT

Warnings/Precautions:

Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, or irritation occurs. Do not use on face, axillae, or groin, or if atrophy is present at treatment site. Avoid eyes, sun, UV light (eg, phototherapy). Treat infection if present. Severe renal or hepatic dysfunction. Allergic contact dermatitis. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Systemic absorption potentiated by other corticosteroids.

Adverse Reactions:

Oint: pruritus, scaly rash. Susp: folliculitis, burning sensation of skin.

How Supplied:

Oint—60g, 100g; Susp—60g, 2x60g

Sign Up for Free e-newsletters